A groundbreaking investigation across four African nations has uncovered a disturbing truth: a significant portion of cancer medications are substandard or counterfeit. This leaves vulnerable patients with treatments that may be ineffective or even harmful. The study, published in The Lancet Global Health, sheds light on a critical and previously unmeasured gap in pharmaceutical regulation on the continent. It highlights…